Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Polycystic Kidney Disease Outcomes Consortium Resource Report Resource Website |
Polycystic Kidney Disease Outcomes Consortium (RRID:SCR_003674) | PKDOC | consortium, data or information resource, organization portal, portal | Consortium to develop evidence supporting the use of imaging Total Kidney Volume (TKV) as a prognostic biomarker that predicts the progression of Autosomal Dominant Polycystic Kidney Disease (ADPKD) to select patients likely to respond to therapy into clinical trials. It aims to replace the currently used measurement of glomerular filtration rate (GFR). Scientists will use the data collected to develop a disease progression model that will evaluate the relationship between TKV and the known complications of ADPKD, including rate of loss of kidney function, hypertension, gross hematuria, kidney stones, urinary tract infections, development of end-stage renal disease, and mortality. These analyses will be used to support the regulatory qualification of TKV as an accepted measure for assessing the progression of ADPKD in clinical trials in which new therapies are tested. PKDOC has the following goals: # Develop standard clinical data elements and definitions that are specific to ADPKD # Create a database of aggregated data from existing multiple, longitudinal, and well-characterized research registries maintained over decades by the leading institutions in ADPKD clinical investigation # Advance and harmonize the missions of regulatory agencies by creating tools that help with the evaluation of new pharmaceutical compounds # Develop a quantitative disease progression model to examine the linkage between TKV and disease outcomes | consortium, drug, imaging, total kidney volume, biomarker, rate, disease progression, imaging biomarker, drug development, kidney volume, kidney, clinical, common data element, therapeutic, clinical trial, standard specification, database |
is listed by: Consortia-pedia has parent organization: Critical Path Institute; Arizona; USA |
PKD Foundation ; Philanthropic donations ; U.S. Food and Drug Administration |
nlx_157909 | SCR_003674 | PKD Outcomes Consortium, PKD Consortium, Polycystic Kidney Disease (PKD) Outcomes Consortium | 2026-09-19 12:50:23 | 0 | |||||||
|
PSTC Nephrotoxicity Biomarkers Resource Report Resource Website |
PSTC Nephrotoxicity Biomarkers (RRID:SCR_003709) | PSTC Nephrotoxicity Biomarkers | data or information resource, narrative resource, standard specification | Urinary kidney biomarkers (KIM-1, albumin, total protein, 2-microglobulin, cystatin C, clusterin and trefoil factor-3) that are considered acceptable biomarkers for the detection of acute drug-induced nephrotoxicity in rats and can be included along with traditional clinical chemistry markers and histopathology in toxicology studies. These biomarkers may be used voluntarily as additional evidence of nephrotoxicity in nonclinical safety assessment studies to complement the standard data (BUN and sCr). In ROC analyses, some of these biomarkers showed better sensitivity and specificity than BUN and sCr relative to histopathological alterations considered to be the gold standard when tested with a limited number of nephrotoxicant and control compounds. | biomarker, drug development, drug, urinary, urinary biomarker, gold standard, kim-1, albumin, total protein, beta2-microglobulin, cystatin c, clusterin, trefoil factor-3, kidney, nonclinical |
is recommended by: U.S. Food and Drug Administration has parent organization: Drug Development Tools Qualification Programs has parent organization: Predictive Safety Testing Consortium |
Nephrotoxicity, Drug-induced nephrotoxicity | Public | nlx_157890 | SCR_003709 | Predictive Safety and Testing Consortium Drug-induced Nephrotoxicity Biomarkers, PSTC NWG Drug-induced Nephrotoxicity Biomarkers | 2026-09-19 12:50:23 | 0 | ||||||
|
Brandeis University; Massachusetts; USA Resource Report Resource Website |
Brandeis University; Massachusetts; USA (RRID:SCR_003669) | university | Private research university located in the Boston suburb of Waltham, Massachusetts. Founded in 1948 as a non-sectarian, coeducational institution sponsored by the Jewish community, Brandeis was established on the site of the former Middlesex University. |
is parent organization of: Paper Rejection Repository is parent organization of: Enhancer Trap Line Browser is parent organization of: Brandeis University Neuroscience Undergraduate Program is parent organization of: Brandeis University Neuroscience Graduate Program is parent organization of: Research Network in Early Experience and Brain Development is parent organization of: Neurofitter is parent organization of: Brandeis University Light Microscopy Core Facility is parent organization of: Brandeis University Louise Mashal Gabbay Cellular Visualization Center Electron Microscopy Core Facility |
nlx_50198, Wikidata:Q49119, ISNI:0000 0004 1936 9473, grid.253264.4, Crossref funder ID:100007864 | https://ror.org/05abbep66 | SCR_003669 | 2026-09-19 12:50:23 | 0 | ||||||||||
|
Academic Drug Discovery Consortium Resource Report Resource Website 1+ mentions |
Academic Drug Discovery Consortium (RRID:SCR_003706) | ADDC, aD2c | consortium, data or information resource, organization portal, portal | A collaborative network among university-led drug discovery centers and programs to allow scientists to exchange technical expertise on drug discovery and development strategies as well as form partnerships with each other, biopharma companies, and drug discovery-focused contract service organizations and consultants. The website will also serve as a repository for drug discovery events, educational material, job postings, and partnership opportunities. Through active member participation this website will become a valuable tool for every scientist working in the drug discovery arena. In addition, involvement of members will enable them to effectively advocate to the NIH and other funding agencies to increase the awareness of the growing number of academic drug discovery scientists and their success as well as their needs. | drug, consortium, drug discovery |
is listed by: Consortia-pedia has parent organization: Johns Hopkins University; Maryland; USA |
SciRes_000146, nlx_157873 | SCR_003706 | Academic Drug Discovery Consortium (ADDC) | 2026-09-19 12:50:23 | 4 | ||||||||
|
eBioscience Resource Report Resource Website 50+ mentions |
eBioscience (RRID:SCR_003660) | commercial organization | An Antibody supplier | nlx_152349 | SCR_003660 | 2026-09-19 12:50:23 | 70 | ||||||||||||
|
Signalway Resource Report Resource Website 10+ mentions |
Signalway (RRID:SCR_003659) | SAB | commercial organization | An Antibody supplier | nlx_152462 | SCR_003659 | Signalway Antibody Co. Ltd | 2026-09-19 12:50:23 | 11 | ||||||||||
|
MIAPA Resource Report Resource Website 1+ mentions |
MIAPA (RRID:SCR_003777) | MIAPA | data or information resource, narrative resource, standard specification | Central hub for resources related to developing and deploying a Minimal Information for a Phylogenetic Analysis (MIAPA) standard. | phylogeny, dna, amino acid sequence |
is listed by: Minimum Information for Biological and Biomedical Investigations is listed by: GitHub is listed by: SourceForge |
PMID:16901231 | nlx_158100 | https://github.com/miapa/miapa/blob/master/checklist/MIAPA-checklist.md, http://mibbi.sourceforge.net/projects/MIAPA.shtml | SCR_003777 | Minimal Information for a Phylogenetic Analysis | 2026-09-19 12:50:25 | 1 | ||||||
|
Experimental Factor Ontology Resource Report Resource Website 10+ mentions |
Experimental Factor Ontology (RRID:SCR_003574) | EFO | controlled vocabulary, data or information resource, ontology | An application focused ontology modelling the experimental factors in ArrayExpress and Gene Expression Atlas. It has been developed to increase the richness of the annotations that are currently made in the ArrayExpress repository, to promote consistent annotation, to facilitate automatic annotation and to integrate external data. The ontology describes cross-product classes from reference ontologies in area such as disease, cell line, cell type and anatomy. The methodology employed in the development of EFO involves construction of mappings to multiple existing domain specific ontologies, such as the Disease Ontology and Cell Type Ontology. This is achieved using a combination of automated and manual curation steps and the use of a phonetic matching algorithm. The ontology is evaluated with use cases from the ArrayExpress repository and ArrayExpress Atlas. You may also browse the EFO in the NCBO Bioportal. Term submissions are welcome. | gene expression, owl, experimental factor, disease, cell line, cell type, anatomy, gold standard |
is listed by: BioPortal is related to: ArrayExpress is related to: ArrayExpress is related to: Gene Expression Atlas has parent organization: European Bioinformatics Institute |
European Molecular Biology Laboratory ; European Union FELICS contract 021902; European Union EMERALD LSHG-CT-2006-037686; European Union Gen2Phen contract 200754 |
PMID:20200009 | The community can contribute to this resource | nlx_11363 | SCR_003574 | 2026-09-19 12:50:22 | 19 | ||||||
|
RAREMETAL Resource Report Resource Website 10+ mentions |
RAREMETAL (RRID:SCR_003573) | RAREMETAL | software resource | A software program that facilitates the meta-analysis of rare variants from genotype arrays or sequencing. | bio.tools |
is listed by: OMICtools is listed by: bio.tools is listed by: Debian has parent organization: University of Michigan; Ann Arbor; USA |
PMID:24894501 | biotools:raremetal, OMICS_00243 | https://bio.tools/raremetal | SCR_003573 | 2026-09-19 12:50:22 | 22 | |||||||
|
Karma Resource Report Resource Website 50+ mentions |
Karma (RRID:SCR_003732) | Karma | data management software, software application, software resource | An information integration software tool that enables users to integrate data from a variety of data sources including databases, spreadsheets, delimited text files, XML, JSON, KML and Web APIs. Users integrate information by modeling it according to an ontology of their choice using a graphical user interface that automates much of the process. Karma learns to recognize the mapping of data to ontology classes and then uses the ontology to propose a model that ties together these classes. Users then interact with the system to adjust the automatically generated model. During this process, users can transform the data as needed to normalize data expressed in different formats and to restructure it. Once the model is complete, users can publish the integrated data as RDF or store it in a database. | integration, FASEB list |
is related to: GitHub has parent organization: University of Southern California; Los Angeles; USA |
Air Force Research Laboratory FA8750-14-C-0240; NCRR 1 U24 RR025736-01; NCRR 1 UL1 RR031986-01; NSF IIS-1117913; NSF CMMI-0753124 |
PMID:15215426 | Apache License, v2 | nlx_157923 | https://github.com/InformationIntegrationGroup/Web-Karma | SCR_003732 | Karma A Data Integration Tool, Karma - A Data Integration Tool | 2026-09-19 12:50:24 | 83 | ||||
|
Alaska Satellite Facility Resource Report Resource Website 1+ mentions |
Alaska Satellite Facility (RRID:SCR_003610) | ASF, ASF SAR DAAC | data repository, service resource, storage service resource | Satellite facility that downlinks, processes, archives, and distributes remote-sensing data to scientific users around the world. Three major components: * Satellite Tracking Ground Station: Part of NASA?s Near Earth Network system of ground stations around the world. * Synthetic Aperture Radar Distributed Active Archive Center (SAR DAAC): ASF maintains the NASA archive of SAR data from a variety of satellites and aircraft, and provides these data and associated specialty support services to U.S. Government-approved researchers in support of NASA?s Earth Science Data and Information System project. * ASF Enterprise Center (ASFE): In support of UAF?s mission to be a student-centered research university, the ASF-E focuses on applications of remote-sensing data, specifically for UAF research. The ASF-E includes the GeoData Center (GDC), which provides data management and archive services for UAF principal investigators and maintains a variety of geophysical data collections in support of scientific research. | remote sensing, earth resources technology satellite, earth, satellite, synthetic aperture radar |
is listed by: re3data.org has parent organization: University of Alaska Fairbanks; Alaska; USA |
Acknowledgement requested, Account required, (for some), Approval required, (for some), Open unspecified license, (some) | nlx_157757, r3d100013015 | https://doi.org/10.17616/R31NJMJB | SCR_003610 | Alaska Satellite Facility - Synthetic Aperture Radar Distributed Active Archive Center | 2026-09-19 12:50:23 | 8 | ||||||
|
Corpus Callosum Thickness Profile Analysis Pipeline Resource Report Resource Website |
Corpus Callosum Thickness Profile Analysis Pipeline (RRID:SCR_003575) | ccsegthickness | software resource | An end-to-end pipeline for corpus callosum processing that provides automated midsagittal alignment, CC segmentation with a quality control tool, and thickness profile generation. Groupwise analysis is facilitated by permutation testing with FWER and FDR multiple comparison correction. Results display is facilitated by a display script that shows p-values on a 3D pipe representation of a CC. This pipeline is implemented in MATLAB and requires the Image Processing Toolbox. There are plans to implement it completely in Python. | linux, matlab, mr, nifti-1, posix/unix-like, corpus callosum | is listed by: NeuroImaging Tools and Resources Collaboratory (NITRC) | PMID:24968872 | GNU General Public License | nlx_157716 | SCR_003575 | 2026-09-19 12:50:22 | 0 | |||||||
|
Medical Diagnostic Categories - Diagnosis Related Groups Resource Report Resource Website |
Medical Diagnostic Categories - Diagnosis Related Groups (RRID:SCR_003725) | MDCDRG | controlled vocabulary, data or information resource, ontology | Ontology of Medical Diagnostic Categories-Diagnosis Related Groups | owl | is listed by: BioPortal | nlx_157470 | SCR_003725 | 2026-09-19 12:50:24 | 0 | |||||||||
|
Polyester Resource Report Resource Website 100+ mentions |
Polyester (RRID:SCR_003602) | data analysis software, data processing software, simulation software, software application, software resource | An R package designed to simulate RNA sequencing experiments with differential transcript expression. Given a set of annotated transcripts, it will simulate the steps of an RNA-seq experiment (fragmentation, reverse-complementing, and sequencing) and produce files containing simulated RNA-seq reads. Simulated reads can be analyzed using a choice of downstream analysis tools. Polyester has a built-in wrapper function to simulate a case/control experiment with differential transcript expression and biological replicates. Users are able to set the levels of differential expression at transcripts of their choosing. This means they know which transcripts are differentially expressed in the simulated dataset, so accuracy of statistical methods for differential expression detection can be analyzed. Polyester offers several unique features: * Built-in functionality to simulate differential expression at the transcript level * Ability to explicitly set differential expression signal strength * Simulation of small datasets, since large RNA-seq datasets can require lots of time and computing resources to analyze * Generation of raw RNA-seq reads, as opposed to alignments or transcript-level abundance estimates * Transparency/open-source code | standalone software, unix/linux, mac os x, windows, r, rna-seq | is listed by: OMICtools | OMICS_04272 | SCR_003602 | 2026-09-19 12:50:23 | 491 | ||||||||||
|
Myelin Repair Foundation Resource Report Resource Website 1+ mentions |
Myelin Repair Foundation (RRID:SCR_003723) | MRF | institution | A non-profit foundation that funds basic research and is focused on accelerating the development of myelin repair therapeutics for multiple sclerosis. They have defined a 15-year research plan to develop a drug or drugs and believes its Accelerated Research Collaborative (ARC) model can subsequently be used to accelerate the treatment for all diseases. The ARC framework coordinates and manages the entire therapeutic development continuum from discovery biology to FDA approval. The model works by coordinating multi-disciplinary basic research from academic and government laboratories, systematically validating and derisking potential compounds/targets, and collaborating with pharma partners to increase the probability of successful programs. | consortium, drug, myelin repair, therapeutic, myelin, drug development | is listed by: Consortia-pedia | Multiple Sclerosis, Neurological disease | nlx_157901, grid.429475.9, Wikidata: Q6947290 | https://ror.org/05yb6xa82 | SCR_003723 | 2026-09-19 12:50:24 | 3 | |||||||
|
Tocris Bioscience Resource Report Resource Website 100+ mentions |
Tocris Bioscience (RRID:SCR_003689) | commercial organization | An Antibody supplier | nlx_152479 | SCR_003689 | 2026-09-19 12:50:23 | 393 | ||||||||||||
|
TransCelerate BioPharma Resource Report Resource Website 1+ mentions |
TransCelerate BioPharma (RRID:SCR_003728) | TransCelerate | nonprofit organization | Non-profit research organization aiming to accelerate drug development by increasing the quality and efficiency of clinical studies through the development of shared tools, methods, and platforms. Consortium partnerships are limited to pharmaceutical and biotechnology companies with research & development operations, although there are collaborations with external organizations such the Clinical Data Interchange Standards Consortium (CDISC). Its current focus is to collaborate on: * Standardizing risk-based monitoring * Development of methods to qualify and train clinical trial sites * Development of a common investigator web portal * Development of clinical data standards on efficacy, and methods for comparator drug trials It currently has 5 projects: # Standardized Approach for High-Quality, Risk-Based Monitoring program aims to develop an industry-wide standard and approach for risk-based monitoring of clinical trials in order to enhance patient safety and ensure the quality of clinical trial data. # Shared Site Qualification and Training program aims to standardize GCP training and site qualification credentials in order to realize efficiencies and accelerate study start-up timelines. # Common Investigator Site Portal is a platform designed to streamline investigator and site access through harmonized delivery of content and services. # Data Standards project is a partnership with CDISC to develop industry-wide data standards in priority therapeutic areas to support the exchange and submission of clinical research and meta-data, improving patient safety and outcomes. # Comparator Drugs project aims to establish reliable, rapid sourcing of quality products for use in clinical trials through a comparator supply model enabling accelerated trial timelines and enhanced patient safety. | drug, clinical trial, multipharma, data sharing, drug development, consortium, medicine, clinical, standard specification | is listed by: Consortia-pedia | Member companies financial contributions ; Member companies in-kind contributions ; GlaxoSmithKline |
nlx_157913 | SCR_003728 | TransCelerate BioPharma Inc. | 2026-09-19 12:50:24 | 6 | |||||||
|
National Brain Databank Resource Report Resource Website |
National Brain Databank (RRID:SCR_003606) | National Brain Databank | data or information resource, data set, database | THIS RESOURCE IS NO LONGER IN SERVICE, documented September 6, 2016. A publicly accessible data repository to provide neuroscience investigators with secure access to cohort collections. The Databank collects and disseminates gene expression data from microarray experiments on brain tissue samples, along with diagnostic results from postmortem studies of neurological and psychiatric disorders. All of the data that is derived from studies of the HBTRC collection is being incorporated into the National Brain Databank. This data is available to the general public, although strict precautions are undertaken to maintain the confidentiality of the brain donors and their family members. The system is designed to incorporate MIAME and MAGE-ML based microarray data sharing standards. Data from various types of studies conducted on brain tissue in the HBTRC collection will be available from studies using different technologies, such as gene expression profiling, quantitative RT-PCR, situ hybridization, and immunocytochemistry and will have the potential for providing powerful insights into the subregional and cellular distribution of genes and/or proteins in different brain regions and eventually in specific subregions and cellular subtypes. | cellular, cortex, sequence data, molecular neuroanatomy resource, gene expression, microarray, brain tissue, post-mortem, neurological disorder, mental disease, human, gene expression profiling, quantitative rt pcr, in situ hybridization, immunocytochemistry, schizophrenia, bipolar disorder, huntington's disease, parkinson's disease | has parent organization: Harvard Brain Tissue Resource Center | Schizophrenia, Huntington's disease, Parkinson's disease, bipolar disorder | NIMH ; NINDS |
THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-00071 | SCR_003606 | National Brain Databank: Brain Tissue Gene Expression Repository | 2026-09-19 12:50:23 | 0 | |||||
|
Project Data Sphere Resource Report Resource Website 10+ mentions |
Project Data Sphere (RRID:SCR_003726) | PDS | consortium, data or information resource, database, organization portal, portal | Initiative to advance oncology research by enabling collaborative sharing of historical oncology clinical trial data through a universal platform (database). The initiative aims to network all stakeholders in the cancer community researchers, industry, academia, advocacy, and other organizations to share insights and collaborate on issues that could not be solved individually. To do this, they have made efforts to address issues of data privacy, security, intellectual property, resources, and incentives as part of its effort to maximize participation. Data contributions include control arms of clinical trials, and the platform uses data-security precautions and analytics to pool multiple studies associated with the same diagnosis in a manner that seeks to protect the privacy of patients and the security of the data contributed. | drug, oncology, clinical trial, data sharing, consortium, phase iii |
is listed by: DataCite is listed by: re3data.org |
PMID:25876994 | nlx_157911, DOI:10.34949, DOI:10.17616/R31NJMJB, r3d100010760 | https://doi.org/10.17616/R36H16, https://doi.org/10.17616/r31NJMJB, https://doi.org/10.34949/, https://dx.doi.org/10.34949/, https://doi.org/10.17616/R3KP67 | SCR_003726 | DataSphere, Project Data Sphere Initiative, Project DataSphere, Project Data Sphere LLC | 2026-09-19 12:50:24 | 43 | ||||||
|
MMRF CoMMpass Study Resource Report Resource Website 1+ mentions |
MMRF CoMMpass Study (RRID:SCR_003721) | CoMMpass | consortium, data or information resource, disease-related portal, organization portal, portal, topical portal | A personalized medicine initiative to discover biomarkers that can better define the biological basis of multiple myeloma to help stratify patients. This effort hopes to obtain samples from approximately 1,000 multiple myeloma patients and follow them over time to identify how a patient's genetic profile is related to clinical progression and treatment response. As a partnership between 17 academic centers, 5 pharmaceuticals and the Department of Veterans Affairs, the goal of this eight year study is to create a database that can accelerate future clinical trials and personalized treatment strategies. MMRF's CoMMpass Study has the following goals: * Create a guide to which treatments work best for specific patient subgroups. * Share data with researchers to accelerate drug development for specific subtypes of multiple myeloma patients. In order to facilitate discoveries and development related to targeted therapies, the comprehensive data from CoMMpass is placed in an open-access research portal. The data will be part of the Multiple Myeloma Research Foundation's (MMRF) Personalized Medicine Platform combines CoMMpass data with those collected from MMRF's Genomics Initiative. It is hoped that the longitudinal data, combined with the annotated bio-specimens will help provide insights that can accelerate personalized therapies. | consortium, biomarker, molecular, genetic, blood, cancer, clinical, data sharing |
uses: Multiple Myeloma Genomics Portal is listed by: Consortia-pedia has parent organization: Multiple Myeloma Research Foundation |
United States Department of Veterans Affairs ; Multiple Myeloma Research Foundation |
nlx_157899 | SCR_003721 | Relating Clinical Outcomes in MM to Personal Assessment of Genetic Profile, Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile Study, Multiple Myeloma Research Foundation (MMRF) - CoMMpass Study | 2026-09-19 12:50:24 | 1 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
